Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation
View abstract on PubMed
Summary
This summary is machine-generated.High-risk human papillomaviruses (HPVs) activate the pentose phosphate pathway (PPP) to promote cervical cancer. HPV16 E6 inhibits G6PD lactylation, enhancing PPP activity and cell proliferation, offering new therapeutic targets.
Area Of Science
- Oncology
- Virology
- Biochemistry
Background
- High-risk human papillomaviruses (HPVs) are primary causes of cervical cancer.
- Oncoproteins like HPV16 E6E7 play a crucial role in cancer development.
- The pentose phosphate pathway (PPP) is vital for cellular metabolism and redox balance.
Purpose Of The Study
- To investigate the mechanism by which HPV16 E6E7 promotes cervical cancer cell proliferation.
- To elucidate the role of the pentose phosphate pathway (PPP) in HPV-associated cervical cancer.
- To identify potential therapeutic targets for cervical cancer treatment.
Main Methods
- Investigated HPV16 E6E7's effect on PPP activation in cervical cancer cells.
- Assessed the impact of HPV16 E6 on glucose-6-phosphate dehydrogenase (G6PD) enzyme activity and lactylation.
- Utilized genetic manipulation (G6PD K45A and K45T mutants) in cell lines and in vivo models.
- Administered 6-aminonicotinamide (6-An) to inhibit G6PD activity in vivo.
Main Results
- HPV16 E6E7 activates the PPP, driving cervical cancer cell proliferation.
- HPV16 E6 increases G6PD activity by inhibiting its lactylation at K45.
- Modulating G6PD lactylation affects cellular redox balance (GSH, NADPH, ROS) and proliferation.
- Inhibition of G6PD activity or mimicking constitutive lactylation suppressed tumor growth in vivo.
Conclusions
- HPV16 E6E7 hijacks the PPP via G6PD lactylation to promote cervical cancer.
- Targeting G6PD lactylation and PPP activity presents a novel therapeutic strategy for HPV-associated cancers.
- This study reveals a new mechanism of HPV-driven oncogenesis.
Related Concept Videos
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

